The table below shows Crinetics Pharmaceuticals, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$10.73M
$143.00K
$1.03M
$361.00K
$0.00
$399.00K
Cost of revenue
$200.00K
-
-
$0.00
-
-
Gross profit
-
-
-
-
-
-
R&D
$100.08M
$90.46M
$80.30M
$76.24M
$61.91M
$58.34M
CRNX annual revenue (10-K history)
Crinetics Pharmaceuticals, Inc. reported annual revenue of $7.70M for fiscal year 2025. That is up 640.7% from $1.04M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $589.00K (FY 2016) to $7.70M. Figures come from the company's audited annual reports as filed with the SEC.